ZKSCAN1 (Gene)

Synonyms:ENTREZ:7586, HGNC:13101, KOX18, MIM:601260, NM_001287054, NM_001287055, NM_001346579, NM_001346580, NM_001346581, NM_003439, NP_001273983, NP_001273984, NP_001333508, NP_001333509, NP_001333510, NP_003430, NR_144477, PHZ-37, XM_011516559, XP_011514861, XR_002956485, XR_927529, ZKSCAN1, ZNF139, ZNF36, ZSCAN33, zinc finger with KRAB and SCAN domains 1
Omim:OMIM:601260
Id:ENSG00000106261
Hgnc:HGNC:13101
Entrez:7586
Description:zinc finger with KRAB and SCAN domains 1
This gene encodes a member of the Kruppel C2H2-type zinc-finger family of proteins. This encoded protein may function as a transcription factor that regulates the expression of GABA type-A receptors in the brain. Transcripts from this gene have been shown to form stable and abundant circular RNAs. Elevated expression of this gene has been observed in gastric cancer and the encoded protein may stimulate migration and invasion of human gastric cancer cells. [provided by RefSeq, Oct 2016]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ZKSCAN1's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ZKSCAN1.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ZKSCAN1.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ZKSCAN1.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ZKSCAN1.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.